Cargando…

Surgical Management of Hepatoblastoma and Recent Advances

Hepatoblastoma is the most common childhood liver malignancy. The management of hepatoblastoma requires multidisciplinary efforts. The five-year overall survival is approximately 80% in developed countries. Surgery remains the mainstay of treatment for hepatoblastoma, and meticulous techniques must...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tianyou, Whitlock, Richard S., Vasudevan, Sanjeev A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966548/
https://www.ncbi.nlm.nih.gov/pubmed/31817219
http://dx.doi.org/10.3390/cancers11121944
_version_ 1783488761118588928
author Yang, Tianyou
Whitlock, Richard S.
Vasudevan, Sanjeev A.
author_facet Yang, Tianyou
Whitlock, Richard S.
Vasudevan, Sanjeev A.
author_sort Yang, Tianyou
collection PubMed
description Hepatoblastoma is the most common childhood liver malignancy. The management of hepatoblastoma requires multidisciplinary efforts. The five-year overall survival is approximately 80% in developed countries. Surgery remains the mainstay of treatment for hepatoblastoma, and meticulous techniques must be employed to ensure safe and effective local control surgeries. Additionally, there have been several advances from both pediatric and adult literature in the way liver tumor surgery is performed. In this review, we highlight important aspects of liver surgery for hepatoblastoma, the management of metastatic disease, and the most current technical advances in performing these procedures in a safe and effective manner.
format Online
Article
Text
id pubmed-6966548
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69665482020-01-27 Surgical Management of Hepatoblastoma and Recent Advances Yang, Tianyou Whitlock, Richard S. Vasudevan, Sanjeev A. Cancers (Basel) Review Hepatoblastoma is the most common childhood liver malignancy. The management of hepatoblastoma requires multidisciplinary efforts. The five-year overall survival is approximately 80% in developed countries. Surgery remains the mainstay of treatment for hepatoblastoma, and meticulous techniques must be employed to ensure safe and effective local control surgeries. Additionally, there have been several advances from both pediatric and adult literature in the way liver tumor surgery is performed. In this review, we highlight important aspects of liver surgery for hepatoblastoma, the management of metastatic disease, and the most current technical advances in performing these procedures in a safe and effective manner. MDPI 2019-12-04 /pmc/articles/PMC6966548/ /pubmed/31817219 http://dx.doi.org/10.3390/cancers11121944 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yang, Tianyou
Whitlock, Richard S.
Vasudevan, Sanjeev A.
Surgical Management of Hepatoblastoma and Recent Advances
title Surgical Management of Hepatoblastoma and Recent Advances
title_full Surgical Management of Hepatoblastoma and Recent Advances
title_fullStr Surgical Management of Hepatoblastoma and Recent Advances
title_full_unstemmed Surgical Management of Hepatoblastoma and Recent Advances
title_short Surgical Management of Hepatoblastoma and Recent Advances
title_sort surgical management of hepatoblastoma and recent advances
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966548/
https://www.ncbi.nlm.nih.gov/pubmed/31817219
http://dx.doi.org/10.3390/cancers11121944
work_keys_str_mv AT yangtianyou surgicalmanagementofhepatoblastomaandrecentadvances
AT whitlockrichards surgicalmanagementofhepatoblastomaandrecentadvances
AT vasudevansanjeeva surgicalmanagementofhepatoblastomaandrecentadvances